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The Herpes Simplex Virus thymidine kinase (HSV-tk) suicide gene/ganciclovir (GCV) approach has been used for the treatment of a
variety of cancers. The purpose of the present study was to evaluate the cytotoxic effect of ganciclovir in oral squamous cancer cells,
previously transfected with HSV-tk gene delivered by transferrin-associated complexes (Tf-lipoplexes), as well as to investigate the
mechanisms involved in the bystander effect and in the process of cell death. The delivery of HSV-tk gene to the oral cancer cells, HSC-3
and SCC-7, mediated by Tf-lipoplexes followed by ganciclovir treatment resulted in essentially 100% cytotoxicity, the observed toxic effect
being dependent both on GCV dose and incubation time. Cell death was shown to occur mainly by an apoptotic process. Different
experimental approaches demonstrated that the observed cytotoxicity was mainly due to diffusion of the toxic agent into neighbouring, non-
transfected cells, via gap junctions. Preliminary in vivo studies in a murine model for oral squamous cell carcinoma have shown a significant
inhibition of tumor growth upon injection of Tf-lipoplexes carrying HSV-tk followed by intraperitonal injection of GCV, as compared to
controls.
© 2006 Elsevier B.V. All rights reserved.Keywords: HSV-tk/GCV suicide gene therapy; Oral carcinoma; Transferrin-associated lipoplexes; Bystander effect; Apoptosis1. Introduction
Head and neck squamous cell carcinoma is a cancer with a
high rate of morbidity and mortality due to insufficient early
diagnosis and treatment. In fact, despite recent advances, the
present therapeutic approaches such as surgery, radiation and
chemotherapy have significant limitations both in terms of
efficacy and ability to prolong survival in patients with advanced
cancer disease [1–3].⁎ Corresponding author. Department of Biochemistry and Center for
Neuroscience and Cell Biology, University of Coimbra, Portugal. Tel.: +351
239 820190; fax: +351 239 853607.
E-mail address: mdelima@ci.uc.pt (M.C. Pedroso de Lima).
0005-2736/$ - see front matter © 2006 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamem.2006.08.021The potential of gene therapy to constitute a viable molecular-
based therapeutic approach has been demonstrated by the
promising results achieved in several pre-clinical studies [4,5].
Strategies for cancer gene therapy include selective prodrug
activation by “suicide” genes, inhibition of activated oncogenes
by antisense oligonucleotides, ribozymes or siRNAs, inhibition
of angiogenesis, transfer of tumor suppressor genes and cytokine
gene transfer [6,7]. Prodrug/suicide gene approach involves the
delivery of a suicide gene into cells, rendering them sensitive to a
specific prodrug [8]. Delivery of the Herpes Simplex Virus
thymidine kinase gene (HSV-tk) to target cells results in
expression of viral thymidine kinase, which selectively phos-
phorylates ganciclovir (GCV). Monophosphorylated GCV is
further phosphorylated by endogenous cellular kinases into an
active triphosphate purine analog compound. This product is
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cell death [9,10]. Although low transfection efficiency is usually
observed, the transfected tumor cells (effector cells) appear to be
capable of inducing the death of neighbouring untransfected
cells, a phenomenon called bystander effect [11]. This effect was
shown to result in extensive cytotoxicity and complete tumor
eradication [12]. The mode by which this effect occurs remains
to be fully understood and different mechanisms have been
proposed, including the formation of apoptotic vesicles contain-
ing the toxic metabolite, which are internalized by neighbouring
cells, the diffusion of the toxic metabolite into non-transfected
cells through gap junctions and the activation of immune system
in vivo [11–13].
One of the major limitations of gene therapy is the effective
delivery of therapeutic genes into target cells. The drawbacks
associated with the use of viral vectors, namely those related
with safety problems, have prompted investigators to develop
alternative methods for gene delivery, cationic lipid-based
systems (lipoplexes) being the most representative. Cationic
liposomes have several attractive features for gene transfer: they
are very easy to prepare, when compared to viral vectors, and
can be administered by several routes and are usually non-toxic
and non-immunogenic at therapeutic doses; in addition, they
can be linked to proteins, fusogenic peptides or associated with
NLS sequences aiming at promoting the intracellular delivery
and nuclear transfer of therapeutic genes, respectively [14–16].
However, some disadvantages including limited efficiency of
delivery and gene expression (as compared to viral vectors),
toxicity at higher concentrations, potentially adverse interac-
tions with negatively charged macromolecules present in serum
and on cell surfaces, and impaired ability to reach tissues
beyond the vasculature unless directly injected into the tissue,
represent restrictions to their wide successful application. We
and others have demonstrated that association of fusogenic
peptides or proteins, including albumin or transferrin, to
lipoplexes results in a significant enhancement of transfection
both in vitro and in vivo [14,17–20].
Since malignant oral squamous cells overexpress transferrin
receptors as compared to non-malignant cells [21,22], we
investigated whether treatment of tongue cancer cells with GCV
would induce significant cell death following delivery of HSV-
tk gene by Tf-lipoplexes. The effect of critical parameters, such
as size and lipid/DNA stoichiometry of the complexes on their
biological activity, was assessed in order to establish the most
efficient transfection conditions for these cells. Studies aiming
at gaining insights into the mechanisms involved in the
observed bystander effect as well as in the process of cell
death were also performed. Moreover, to evaluate the in vivo
potential of Tf-lipoplexes in HSV-tk/GCV therapy of oral
cancer, exploratory work was carried out in a syngeneic
orthotopic murine model for squamous cell carcinoma of the
head and neck.
To our knowledge, this is the first systematic study addressing
the use of Tf- lipoplexes for the in vitro and in vivo application of
suicide gene therapy approaches aiming at treating oral
squamous cell carcinoma and understanding the underlying
mechanisms.2. Materials and methods
2.1. Chemicals
The cationic lipid 1,2-dioleoyl-3-(trimethylammonium) propane (DOTAP),
and cholesterol (chol), were purchased from Avanti Polar Lipids (Alabaster, AL,
USA). Iron-saturated human transferrin was obtained from Sigma (St. Louis,
MO, USA).The pCMVluc plasmid (VR-1216) was kindly provided by Dr. P.
Felgner (Vical, San Diego, CA, USA) and the plasmid pCMVtk was kindly
provided by Dr. N. Düzgünes (University of the Pacific, San Francisco, CA,
USA). Alamar Blue dye was purchased from Trek diagnostics systems (Ohio,
USA). α-glycyrrhetinic acid (AGA) and dibutyryl adenosine 3′,5′-cyclic
monophosphate (db-cAMP) were obtained from Sigma (St. Louis, MO, USA).
Ganciclovir (GCV) was a gift from the University Hospital of Coimbra.
2.2. Cells
HSC-3 (human squamous cells) and SCC-7 (murine squamous cells) cells,
kindly provided by Dr. N. Düzgünes (University of the Pacific, San Francisco,
CA, USA), were maintained at 37 °C, under 5% CO2, in Dulbecco's modified
Eagle's medium-high glucose (DMEM-HG) (Sigma, St. Louis, MO, USA)
supplemented with 10% (v/v) heat-inactivated fetal bovine serum (FBS) (Sigma,
St. Louis, MO, USA), penicillin (100 U/ml), streptomycin (100 μg/ml) and
sodium bicarbonate (1.6 g/l). For transfection, 1×105 HSC-3 or SCC-7 cells
were seeded in 1 ml of DMEM medium in 48-well culture plates 24 h before
transfection and used at 70–80% confluence.
2.3. Cationic liposomes and lipoplexes
Small unilamellar cationic liposomes (SUV) were prepared by extrusion of
multilamellar liposomes (MLV) composed of a 1:1 (mole ratio) mixture of 1,2-
dioleoyl-3-(trimethylammonium) propane (DOTAP) and cholesterol (Chol).
Briefly, lipids (Avanti Polar Lipids, Alabaster, AL, USA) dissolved in CHCl3
were mixed at the desired molar ratio and dried under vacuum in a rotatory
evaporator. The dried lipid film was hydrated with deionised water to a final
lipid concentration of 6 mM and the resulting MLV were then sonicated for
3 min, and extruded, 21 times, through two stacked polycarbonate filters of
50 nm pore diameter using a Liposofast device (Avestin, Toronto, Canada). The
resulting liposomes (SUV) were then diluted five times with deionised water and
filter-sterilised utilising 0.22 mm pore-diameter filters (Schleicher and Schuell
BioScience, Germany). For the in vitro studies, complexes were prepared by
sequentially mixing 100 μl of a HEPES-buffered saline solution (HBS)
(100 mM NaCl, 20 mM HEPES, pH 7.4), with or without human transferrin
(320 μg/ml) (Sigma, St.Louis, MO, USA), with liposomes (volume was
dependent on the desired lipid/DNA (+/−) charge ratio) and incubated for
15 min at room temperature. One hundred microliters of HBS containing 1 μg of
pCMVluc or 1 μg of pCMVtk were added to the mixture and further incubated
for 15 min at room temperature. For the in vivo studies, complexes were
prepared by sequentially mixing 20 μl of a HBS solution containing human
transferrin (Sigma, St.Louis, MO, USA) (128 μg/ml), with liposomes and
incubated for 15 min at room temperature. Forty microliters of HBS containing
40 μg of pCMVtk were added to the mixture and further incubated for 15 min at
room temperature.
Freshly prepared cationic liposome/DNA complexes, associated or not with
human transferrin, were characterized with respect to their size and zeta potential
using a Coulter N4 plus and a Coulter DELSA 440 (Coulter Corporation,
Miami, FL), respectively as described previously [23].
2.4. Transfection activity
Transfection activity mediated by the complexes was evaluated as described
previously [18]. Cells were rinsed twice with serum-free medium and then
covered with 0.3 ml of DMEM-HG (without serum, unless indicated otherwise)
before lipid-based complexes were added. The complexes were added gently to
cells in a volume of 0.2 ml per well. After incubation for 4 h (in 5% CO2 at
37 °C), the medium was replaced with DMEM-HG containing 10% FBS, and
the cells were further incubated under different experimental conditions. Forty-
1705S.S. Neves et al. / Biochimica et Biophysica Acta 1758 (2006) 1703–1712eight hours after transfection cells were washed twice with phosphate-buffered
saline solution (PBS) (0.14 mM NaCl, 2.7 mM KCl, 1.5 mM KH2PO4, 8.1 mM
Na2HPO4, pH 7.4) and 100 μl of lysis buffer (1 mM DTT, 1 mM EDTA, 25 mM
Tris–phosphate at pH 7.8, 8 mM MgCl2, 15% glycerol, 1% (v/v) Triton X-100)
were added to each well. The level of gene expression in the lysates was
evaluated by measuring light production by luciferase in a Mediators PhL
luminometer (Mediators Diagnostika, Vienna, Austria) and using a standard
curve for luciferase activity. The protein content of the lysates was measured by
the Dc Protein Assay reagent (Bio-Rad, Hercules, CA) using bovine serum
albumin as the standard. The data were expressed as nanograms of luciferase per
milligram of total cell protein.
2.5. Cytotoxicity studies
Following transfection, cell viability was quantified by a modified Alamar
Blue assay (Trek diagnostics systems, Ohio, USA) under the different
experimental conditions. Five hundred microliters of 10% (v/v) Alamar Blue
in DMEM were added to cells. After 2 h incubation at 37 °C, 200 μl of
supernatant were collected from each well and transferred to 96-well plates. The
absorbance at 570 nm and 600 nm was measured using a Mediators PhL
luminometer (Mediators Diagnostika, Vienna, Austria). Cell viability (as a
percentage of control) was calculated according to the formula (A570−A600) of
treated cells×100/ (A570−A600) of control cells [18]. For assessing the cytotoxic
effect of ganciclovir, following transfection with lipid/HSV-tk plasmid DNA
complexes, the culture medium was replaced every day by a fresh solution
containing 10% FBS and ganciclovir at different concentrations.
2.6. Modulation of gap junctional intercellular communication
For the experiments on the effect of modulation of gap junctions on connexin
expression, HSC-3 or SCC-7 cells were incubated with α-glycyrrhetinic acid
(AGA) (50 μM) or dibutyryl adenosine 3′,5′-cyclic monophosphate (db-cAMP)
(500 μM) for 24 h. Cells were trypsinized, centrifuged at 300×g for 5 min and
then permeabilized using a Fix and Perm® kit (Invitrogen, California, USA).
Cells were washed with PBS and incubated for 15 min with primary antibodies:
mouse anti-connexin 43 (Santa Cruz Biotechnology, California, USA) or anti-
dephosphorylated connexin 43 (Invitrogen, California, USA). Cells were then
washed with PBS and incubated with anti-mouse secondary antibody conjugated
with FITC (Dako, Glostrup, Denmark) for 20 min. Cells were further washed
with PBS, resuspended in the same buffer and analysed in a FACSCalibur
(Becton Dickinson) flow cytometer equipped with an argon ion laser emitting at
488 nm.
For the experiments on the effect of the modulation of gap junctions on HSV-
tk/GCV therapy, 1×105 HSC-3 or SCC-7 cells were seeded in 48-well culture
plates (1 ml of medium) and treated with AGA (25 or 50 μM). In parallel
experiments, cells were treatedwith db-cAMP (250 or 500μM) in the presence of
cAMP phosphodiesterase 4 selective inhibitor, 4-(3-butoxy-4-methoxybenzyl)-
2-imidazolidinone (10 μM) (Biomol international L.P., PA, USA). When cells
reached 70–80% confluence, they were transfected with Tf-lipoplexes contain-
ing HSV-tk, as described above. After 4 h of transfection, the medium was
replaced with DMEM-HG containing 10% FBS, GCV (at different concentra-
tions depending on the GJIC modulator tested) and the drugs, this mixture being
freshly prepared and added every day to the cells.
2.7. Morphological analysis
Following transfection, HSC-3 cells, treated or not with GCV, were
trypsinized and centrifuged at 200×g for 5 min. 0.3×106 cells were then
resuspended in 30 μl of FBS and placed on a slide for microscopic analysis.
The cells were stained upon incubation for 5 min with May–Grünwald
solution (0.3% v/v in methanol) (Sigma, St. Louis, MO, USA), diluted in
distilled water at 1:1 (v/v) ratio and then stained with Giemsa solution (0.75%
w/v in glycerol/methanol 1:1) (Sigma, St. Louis, MO, USA) previously diluted
in distilled water (8×). After rinsed with distilled water, the cells were left to
dry at room temperature. Cell morphology was analysed by light microscopy
using a Leitz Dialux 20 microscope associated with a Canon Powershot S40
digital camera.2.8. Mechanistic studies of cell death
Different approaches were used to evaluate the contribution of apoptotic or
necrotic processes to cell death induced by GCV treatment of HSV-tk
transfected HSC-3 cells. Chromatin condensation was analysed by fluorescence
microscopy (Nikon Diaphot with xenon lamp Nikon XPS-100 and Triple filter
Omega FX 64) using the probes SYTO-13 (Molecular Probes) and propidium
iodide (PI). SYTO-13 labels RNA and DNA in live cells with an UV-excited
green emission and PI is excluded from viable cells, with an UV-excited red
emission. Cells (5×104) were incubated for 3 min in a 20 μl solution of sodium
medium: 140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1 mM NaH2PO4, 1.5 mM
CaCl2, 5.6 mM glucose, 20 mM HEPES (pH 7.4), containing 4 ìM SYTO-13
and 4 μg/ml PI.
Quantification of the relative contribution of apoptosis or necrosis to cell
death was performed by flow cytometry [24]. For that purpose, HSC-3 cells
were stained with Annexin V (AV), labelled with the fluorescent probe
fluorescein isothiocyanate (FITC), and PI. Following transfection, the cells
treated or not with GCV for different times, were trypsinized, centrifuged at
300×g for 5 min and incubated for 10 min at 4 °C with 440 μL Annexin buffer
containing 5 μl FITC-labeled AV (Kit from Immunotech SA, Marseille, France)
and 5 μl PI. Cells were then washed with phosphate buffer (PBS), resuspended
in the same buffer and analysed in a FACSCalibur (Becton Dickinson) flow
cytometer equipped with an argon ion laser emitting at 488 nm. The
fluorescence of AV-FITC and PI was evaluated at 525 and 610 nm, respectively.
The results were expressed as percentage of viable, apoptotic and necrotic cells.
2.9. In vivo studies
In vivo experiments were performed using a syngeneic orthotopic murine
model for squamous cell carcinoma of the head and neck developed by
O'Malley et al [25,26]. Six to eight week old female C3H/HeJ mice were
anesthetized upon intramuscular injection of a mixture of chlorpromazine
(2 mg/kg) and ketamine (100 mg/kg). The tumor model was established by
injecting 1×105 SCC-7 cells directly into the floor of the mouse. Five days
after cell implantation, the mice were anesthetized as before, and the
developed tumors were injected with 40 μg of naked DNA (in PBS) or 40 μg
of DNA complexed with transferrin-associated lipoplexes. PBS alone was
also injected into control animals. Four hours after, mice were injected with
ganciclovir (25 mg/kg) intraperitoneally twice a day during 8 days and
sacrificed 13 days following tumor implantation. The tumors were measured
in 3 dimensions everyday with callipers.
2.10. Statistical analysis
Data were analysed using the Prism software (version 4.0). Statistically
significant differences (p<0.001) between the experimental groups were
determined by one-way analysis of variance (ANOVA).
3. Results
3.1. Effect of lipid/DNA (+/−) charge ratio and association of
transferrin on the transfection activity of oral squamous cancer
cells
We evaluated the effect of lipid/DNA charge ratio and
association of transferrin on the transfection activity of cationic
liposome/DNA complexes, containing DOTAP/Chol, in HSC-3
cells. For plain lipoplexes, the highest biological activity was
observed when they were prepared at the 2/1 (+/−) charge ratio
(at which they exhibit a small mean diameter and a positive
surface charge) (Fig. 1). An enhancement of transfection was
observed upon association of transferrin to the lipoplexes for
almost all charge ratios, this being more significant at the 1/1
and 3/2 charge ratios. For the Tf-lipoplexes the highest values of
Fig. 1. Effect of associating transferrin to lipoplexes, prepared at different lipid/
DNA charge ratios, on luciferase gene expression in HSC-3 cells. Cells were
transfected with DOTAP:Chol liposomes, complexed with 1 μg of pCMVluc at
the indicated lipid/DNA (+/−) charge ratios in the absence (plain lipoplexes) or
presence of 32 μg of transferrin (Tf-lipoplexes) as described in Materials and
methods. Data represent the mean±S.D. of at least three independent
experiments performed in triplicate. As expected neutrally charged lipoplexes
(e.g. 3/2 (+/−) charge ratio) tend to form large aggregates (mean size ranging
from 1500 to 2000 nm) as opposed to lipoplexes prepared at high or low (+/−)
charge ratios. Association of transferrin to the lipoplexes results in a decrease of
the zeta potential, this being particularly evident for the 2/1 and 4/1 charge
ratios. Nevertheless, the tendency of the complexes, prepared at a (+/−) charge
ratio close to neutrality, to aggregate is not affected by the presence of this
protein.
Fig. 2. Duration of transgene expression in HSC-3 cells. Cells were transfected
with Tf-lipoplexes composed of DOTAP:Chol/ pCMVluc/transferrin, prepared
at the 3/2 (+/−) charge ratio. The levels of luciferase gene expression were
evaluated as described in Materials and methods. Data represent the mean±S.D.
of at least three independent experiments performed in triplicate.
Fig. 3. Effect of GCV concentration and incubation time on the viability of HSC-
3 cells (A) and SCC-7 cells (B) transfected with HSV-tk. Cells were transfected
with Tf-lipoplexes composed of DOTAP:Chol/ pCMV-tk /transferrin, (3/2 (+/−)
charge ratio) followed by GCV treatment at the indicated doses and incubation
times. Cell viability was evaluated by the Alamar Blue assay. Control represents
cells (non-transfected) treated with 100 μMGCV. Data represent the mean±S.D.
of at least three independent experiments performed in triplicate.
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charge ratio, the zeta potential is close to neutrality and large
aggregates are formed. Similar results were obtained for SCC-7
cells, in terms of enhancement of the transfection efficiency
when lipoplexes were associated with transferrin. The highest
transfection activity was also achieved when transferrin-
associated lipoplexes were prepared at the 3/2 charge ratio
(data not shown). Based on the obtained results, 3/2 (+/−)
charge ratio Tf-lipoplexes were selected as the optimal
formulation for transfection of both HSC-3 and SCC-7 cells
and therefore used for further studies. Using this formulation,
results on the duration of transgene expression reveal that the
highest values of luciferase gene expression are achieved at
48 h. Nevertheless, the transient nature of transfection was
reflected by the significant decrease of gene expression
observed at 3 days and its total abolishment at 7 days, following
incubation of the complexes with the cells for 4 h (Fig. 2).
3.2. Effect of GCV treatment on the viability of oral squamous
cancer cells transfected with HSV-tk
In order to evaluate the cytotoxic effect induced by the HSV-
tk/GCV suicide gene approach, HSC-3 and SCC-7 cells were
transfected with Tf-lipoplexes (composed of DOTAP:Chol/
DNA) prepared at the 3/2 (+/−) lipid/DNA charge ratio and then
incubated for different times with GCVat various concentrations
(up to 100 μM). The extent of cytotoxicity was assessed by the
Alamar Blue assay. A decrease in cell viability was observed
upon increasing GCV concentration, the highest toxicity being
obtained at 100 μM GCV for both cell lines (Fig. 3). As
illustrated in Fig. 3, GCV does not exert any toxic effect in non-
transfected cells. The observed cytotoxic effect was also foundto be dependent on the incubation time of GCV with transfected
cells, this effect being particularly evident at 100 μM GCV
concentration, where essentially 100% cytotoxicity was
observed at 7 days incubation for HSC-3 cells and at 5 days
for SCC-7 cells. Therefore, SCC-7 cells seem to be more
sensitive to GCV than HSC-3 cells, since for the same GCV
concentration and incubation time, a higher toxicity was
observed in SCC-7 cells. Our results illustrate that cell death
induced byGCVis a relatively slow process, since after 3 days of
cell treatment with GCVonly 30–40% reduction in cell viability
was achieved for the highest concentration tested. Independently
of the incubation time, no further toxicity was observed for GCV
concentrations above 100 μM (data not shown). These results
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limiting factor affecting cytotoxicity is the level of thymidine
kinase expression.
3.3. Cellular mechanisms involved in the bystander effect
Evaluation of transfection efficiency mediated by Tf-
lipoplexes, as assessed by scoring the percentage of cells that
were positive for β-galactosidase staining, indicates that only
about 5–10% of cells were successfully transfected (data not
shown). Based on this finding and taking into account that: (i)
the results illustrated in Fig. 2 clearly indicate that transgene
expression under the control of CMV promoter (used for both
luciferase and thymidine kinase plasmids) is transient when
transfection is mediated by Tf-lipoplexes; (ii) TK and
luciferase exhibit similar short half-lives (0.5 and 3 h,
respectively) [27,28]; (iii) phosphorylated GCV exhibits a
short half-life (3–12 h) [29] and (iv) a large extent of cytotoxicity
after 7 days is still observed when cell treatment with GCV is
restricted to the first 3 days following transfection (data not
shown), it can be suggested that the observed delayed cytotoxic
response should be attributed to a rapid diffusion of phosphory-
lated GCV to non-transfected cells, thus triggering further
mechanisms of cell death, which can require long times to occur.
However, the hypothesis of signalling pathways triggered by the
DNA damages observed in transfected cells having a slow effect
in the neighbouring cells cannot be ruled out.
On the other hand, the possibility of phosphorylated
ganciclovir to be present in the cell culture medium and thus
available to reach non-transfected cells is also excluded. This
was demonstrated by the absence of cell death when the
supernatant of GCV-treated, transfected cells, collected after 2,
5 or 7 days incubation with this drug, was added to non-treated,
transfected cells (Fig. 4). These results suggest that the observed
cytotoxicity is due to diffusion of the toxic agent into
neighbouring cells via intercellular communication pathways,
such as gap junctions.
In order to investigate the possible role of gap junctions in
the observed cytotoxic effect, we have evaluated the extent of
connexin expression in HSC-3 and SCC-7 cells, as well as the
effect on modulation of expression and functionality of gapFig. 4. Viability of non-transfected HCS-3 cells upon incubation with medium
collected from cells transfected with HSV-tk and treated with 100 μMGCV. Cell
viability was evaluated by Alamar Blue assay over different incubation periods.
Data represent the mean±S.D. of at least three independent experiments
performed in triplicate.junctions upon incubation of the cells with an activator (db-
cAMP) and an inhibitor (AGA) (Fig. 5). A significant
enhancement of connexin expression was observed in both
HSC-3 and SCC-7 cells (two fold increases), upon their
incubation for 24 h with db-cAMP, as assessed by flow
cytometry using an antibody anti-connexin 43. In contrast,
incubation of the cells with AGA did not result in a significant
effect in connexin 43 expression. In addition, we evaluated the
effect of the gap junctions' modulators on phosphorylation of
connexins, using a specific antibody against the dephosphory-
lated form of connexin 43. It is known that connexin
phosphorylation or dephosphorylation play a role in the
conductivity of gap junctions (by opening or closing) [30].
Our results demonstrate that AGA induces dephosphorylation
of connexin 43 in both cell lines. On the other hand, in the
presence of db-cAMP an increase in phosphorylated connexin
43 expression was observed.
In order to further confirm the role of gap junctions in the
bystander effect, the influence of activating or inhibiting gap
junctions on the extent of cytotoxicity was assessed by treating
both HSC-3 and SCC- 7 cells with db-cAMP and AGA. In both
cases, we observed a concentration-dependent effect on GCV
cytotoxicity only after 5 days incubation with ganciclovir in the
presence of gap junctions' modulators. Upon optimization of
the experimental conditions, a significant inhibition of cyto-
toxicity was observed when both cell types were pre-treated
with 50 μM AGA (60% cell viability was achieved at 5 days
incubation with 50 μM GCV, as compared to 25% cell viability
in the absence of AGA) (Fig. 6B). On the other hand, for the
same incubation time, cytotoxicity mediated by 25 μM
ganciclovir increases from 25% to 60% when the cells were
pre-treated with 500 μM db-cAMP (Fig. 6A). Incubation of the
cells with the gap junctions' modulators at the tested
concentrations did not result in any toxicity (data not shown).
3.4. Molecular mechanisms of cell death mediated by HSV-tk/
GCV gene therapy
Aiming at gaining insights into the molecular mechanisms
involved in the process of cell death induced by the HSV-tk/
GCV system, different experimental approaches were used to
evaluate the relative extent of apoptosis versus necrosis.
At a first approach, following 48 h of transfection with HSV-
tk, HSC-3 cells (treated or not with GCV) were fixed and
stained using a May–Grünwald solution and a Giemsa solution,
as described in Materials and methods. As can be observed in
Fig. 7A, the morphology of transfected cells treated with GCV
suggests that an apoptotic process is occurring, as indicated by
the presence of apoptotic vesicles and condensed nuclei. In
order to confirm these apoptotic events, and to be able to
distinguish among viable, apoptotic and necrotic cells, HSC-3
cells were analysed by fluorescence microscopy upon their
incubation with SYTO-13 or PI.
As illustrated in Fig. 7B, 10% of cells are apoptotic in
transfected cultures not treated with GCV, as assessed by
scoring the cells for fragmented or condensed DNA. However,
following treatment with 100 μM GCV for 2 days, the
Fig. 5. Modulation of connexin expression and phosphorylation by gap junction modulators. Cells were incubated for 24 h with 50 μM AGA or 500 μM db-cAMP.
Connexin 43 expression (total) was determined by FACS analysis using a mouse antibody anti-connexin 43 (Santa Cruz Biotechnology, California, USA) and the
extent of connexin 43 phosphorylation was assessed using a mouse antibody anti-dephosphorylated connexin 43 (Invitrogen, California, USA). Data are shown as
mean fluorescence intensity (MIF) (percentage of untreated cells (control)). Data represent the mean±S.D. of at least two independent experiments. Statistical
significance between experimental groups was determined by one-way ANOVA analysis (***p<0.001; ns p>0.05).
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necrotic cells are observed (as assessed by scoring the cells
incorporating PI).
In order to quantify the extent of apoptosis, we used a flow
cytometry assay based on staining the cells with FITC-AVor PI.Fig. 6. Effect of modulating gap junctions of oral cancer cells (HSC-3 and SCC-7 ce
DOTAP:Chol/ pCMV-tk /transferrin (3/2 charge ratio) following treatment with (A)
various concentrations of AGA and then incubated with 50 μMGCV. Cell viability w
three independent experiments performed in triplicate. Statistical significance b
(***p<0.001; ns p>0.05).With this assay it is possible to distinguish non-apoptotic live
cells (AV negative/PI negative), early apoptotic cells (AV
positive/PI negative) and late apoptotic or necrotic cells (PI
positive) [24]. AV binds with high affinity to negatively charged
phospholipids, namely phosphatidylserine, which is exposed atlls) on the bystander effect. Cells were transfected with complexes composed of
various concentrations of dbAMPc and then incubated with 25 μM GCVor (B)
as evaluated by the Alamar Blue assay. Data represent the mean±S.D. of at least
etween experimental groups was determined by one-way ANOVA analysis
Fig. 7. Morphology of HSC-3 cells as assessed by (A) optical microscopy following cell fixation and staining with May–Grünwald–Giemsa solution and (B)
fluorescence microscopy using SYTO-13™ and PI. Cells were analysed 48 h after being transfected with HSV-tk and treated or not with 100 μM GCV.
Fig. 8. Extent of apoptosis and necrosis of HSC-3 cells transfected with HSV-tk
followed by GCV treatment. Cells were transfected with Tf-lipoplexes followed
by treatment with 100 μM GCV. The cells were then incubated with AV and PI
and analysed by flow cytometry. Control represents transfected but not GCV
treated cells. Results are expressed as the percentage of viable, apoptotic and
necrotic cells at different GCV incubation times and represent the mean±
standard deviation obtained from duplicate wells.
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specific DNA labelling agent that penetrates dead cells due to
the loss of membrane integrity, frequently associated with
necrosis. As shown in Fig. 8, apoptosis seems to be the main
mechanism involved in the death of HSV-tk transfected cells
treated with GCV. An increase in the percentage of apoptotic
cells with increasing the incubation time with 100 μM GCV is
observed (15%, 35% and 50% for 2, 4 and 6 days incubation,
respectively). In contrast, the percentage of necrotic cells
remains essentially the same (approximately 10%) during the
first 4 days of incubation with GCV.
3.5. In vivo studies
To investigate whether intratumoral delivery of the HSV-tk
gene mediated by transferrin-associated lipoplexes would result
in tumor cell killing and size reduction upon GCV treatment, we
used a syngeneic orthotopic murine model for squamous cell
carcinoma of the head and neck [25,26]. Twenty-four C3H/HeJ
mice with an established tumor in the floor of the mouth (10–
25 mm3) were divided into 3 different experimental groups. The
first group of animals was injected intratumorally with PBS
(control), while the second and third groups were injected with
40 μg of DNA encoding HSV-tk, either naked or complexed
with Tf-lipoplexes, respectively. The second and third groups of
animals were subsequently injected twice a day with 25 mg/kg
GCV. Animals were observed daily with special attention to
tumor size, which was measured in 3 dimensions with callipers.
As illustrated in Fig. 9, injection of Tf-lipoplexes is significantly
more effective in delaying tumor progression than PBS or naked
DNA injections. Eight days after treatment, mice that have been
injected with Tf-lipoplexes present a tumor with a size of500 mm3, while the tumor size of both control mice and mice
that have received naked DNA reach 1000–1500 mm3.
4. Discussion
Although numerous studies have been reported regarding the
anti-tumor effect of the HSV-tk/GCV approach on human oral
squamous cell carcinomas, the great majority rely on the use of
viral vectors to mediate gene delivery [25,31–33]. The use of
non-viral vectors for this specific purpose [34–36] has been
scarce, most likely due to their low transfection activity. To our
best knowledge, this is the first systematic report on the use of
protein-associated lipoplexes aiming at application of the above
suicide gene approach for the treatment of human oral
Fig. 9. Antitumor effect of HSV-tk expression followed by treatment with GCV
in an orthotopic mouse model of oral carcinoma. Five days after SCC-7 cell
implantation, tumors were treated with 40 μg naked DNA or Tf-lipoplexes
composed of DOTAP:Chol at 3/2 (+/−) lipid/DNA charge ratio (40 μg DNA).
Mice were then injected twice a day with 25 mg/kg GCV for 8 days. Control
mice were injected with PBS. The tumor size was measured everyday with
callipers and mice were sacrificed 13 days after tumor cell implantation. Results
represent the tumor size after treatment (mean±standard deviation) of different
experimental groups (n=8). Statistical significance between experimental
groups was determined by one-way ANOVA analysis (***p<0.001; ns
p>0.05).
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as well as evaluation of biological activity, both in vitro and in
vivo.
In this work, we evaluated the in vitro efficacy of the HSV-
tk/GCV system, for treatment of oral squamous cancer cells
using Tf-lipoplexes, prepared from cationic liposomes com-
posed of DOTAP:Chol (1:1 mol ratio).
We and others have demonstrated that association of
fusogenic peptides or proteins, including albumin or transferrin,
to lipoplexes potentiates cellular internalization and cytoplasmic
delivery of carried DNA leading to a significant enhancement of
transfection both in vitro and in vivo [14,17–20].
The highest levels of transfection activity for both HSC-3
and SCC-7 cells were observed for transferrin-associated
lipoplexes prepared at a 3/2 (+/−) charge ratio. A significant
enhancement of transfection activity was observed upon
association of transferrin, confirming previous observations
that this protein promotes both internalization of the complexes
and intracellular delivery of DNA.
Our results show that the extent of cell toxicity is GCV
dose-dependent, the highest cytotoxicity (essentially 100% cell
death) being obtained with 100 μM GCV for both, the human
squamous HSC-3 and murine squamous SCC-7 cells. Such
concentration of GCV is higher than those reported to result in
cytotoxicity in other studies, namely using viral vectors [32],
which can be attributed to the lower efficiency of lipid-based
carriers to mediate HSV-tk gene transfer. Cell death induced by
this approach was revealed to be a slow process, since 100%
toxicity was achieved for SCC-7 and HSC-3 cells only after 5
and 7 days incubation with GCV, respectively. However, SCC-
7 cells seem to be more sensitive than HSC-3 cells to
ganciclovir. The time required for cell death to occur depends
on the division rate of the cells. Cells with a higher division
rate are more sensitive to phosphorylated GCV than those with
a lower division rate, this being attributed to the mechanismsof action of the toxic metabolite. The phosphorylated GCV
requires cells under division for effectiveness since it acts
during DNA synthesis, being incorporated and causing chain
termination and cell death. Some studies with ARA-C, an
inhibitor of cell growth, show that cells treated with this drug
become less sensitive to phosphorylated GCV that non-treated
cells [37].
The transfection studies performed with reporter genes
(luciferase) demonstrate that transfection of HSC-3 cells
mediated by Tf-lipoplexes is transient, a significant decrease
of gene expression being observed 72 h after transfection. In
addition, this approach was shown to lead to relatively low
values of transfection efficiency (5–10% successfully trans-
fected cells) Accordingly, the high toxicity observed 7 days
after transfection of the HSC-3 cells with HSV-tk gene
(essentially 100% cell death) cannot be attributed to long term
expression of thymidine kinase and continuous phosphorylation
of GCV, but most likely to a bystander effect. This phenomenon
is clinically important, as genetic modification of all tumor cells
is not possible with the available gene transfer approaches.
Different mechanisms have been proposed to explain this
effect. As stated above, the diffusion, across the cell membrane,
of phosphorylated GCV released from transfected cells to non-
transfected cells is excluded. Therefore, other putative mechan-
isms, namely intercellular transfer of phosphorylated GCV from
transfected to neighbouring non-transfected cells through gap
junctions were investigated.
The implication of gap junctions in the bystander effect was
confirmed by assessing the influence of AGA, a gap junction
blocker [38], on the cytotoxicity mediated by GCV. Connexins
constitute a family of proteins involved in the establishment of
gap junctions, through which intercellular exchange of small
hydrophilic molecules occurs [37,39]. AGA exhibits an
inhibitory effect on gap junctions via direct interaction with
connexins altering connexon particle packing in gap junction
plaques and by dephosphorylation of connexin 43. Phosphor-
ylation of this protein may be necessary for the formation of
active gap junctions. On the other hand, exposure to AGA may
not affect protein synthesis [38,40]. Our results on the effect of
gap junction modulators on connexin 43 expression and
phosphorylation have confirmed that AGA does not affect
connexin 43 expression (as assessed by flow cytometry using an
anti-connexin 43 antibody) but promotes its dephosphorylation
(as assessed by flow cytometry using an anti-connexin 43
antibody specific to the non-phosphorylated form).
The fact that some toxicity could still be observed was due
most likely to an incomplete inhibition of gap junctions by
50 μM AGA. A complete blockage of gap junctional
intercellular communication (GJIC) would have required a
higher AGA concentration, which could not be achieved due to
its cytotoxic effect (data not shown). Guo et al. made the
important observation that functional effectiveness of AGAwas
reduced by serum in a dose-dependent manner most likely due
to binding of the drug to serum proteins. In our protocol, we
used 10% FBS in the medium, so the incomplete blockage of
gap junctions can be explained by these findings [38]. On the
other hand, it should be considered that other mechanisms may
1711S.S. Neves et al. / Biochimica et Biophysica Acta 1758 (2006) 1703–1712also be involved in the bystander effect in HSC-3 and SCC-7
cells.
Since most tumor cells exhibit a reduced level of GJIC [41],
an elegant way to increase the extent of the bystander effect
induced by the HSV-tk/GCV system would be to promote the
GJIC levels [42,43]. This hypothesis was strongly supported by
the fact that the bystander effect is absent in cells that lack
functional gap junctions, but can be restored or enhanced by
connexin gene transfection [44]. cAMP analogs have been
reported to enhance GJIC in a variety of cell lines by promoting
connexin expression [37,39,45]. Recent studies have indicated
that cAMP induces a large increase in connexin mRNA levels in
different tumor cell lines, suggesting that this increase accounts
for the permeability changes induced by this agent [46,47]. In
addition, a different form of control of junctional permeability
by cAMP in which the cellular distribution of connexin 43 is
modified to increase the gap junctional permeance was reported
[48]. Moreover, cAMP can also cause an increase in gap
junctional intercellular communications by phosphorylation of
connexins via protein kinase A [49]. Our results on an increase
of connexin 43 and on a decrease of the non-phosphorylated
form of connexin 43, when the cells were incubated with db-
cAMP for 24 h, as compared to non-treated cells, were
consistent with the above reports.
In this regard, our results show that treatment of both HSC-3
and SCC-7 cells with db-cAMP leads to an increase of the
bystander effect, as illustrated by the higher levels of toxicity
when transfected cells were treated with GCV in the presence of
db-cAMP, as compared to transfected cells treated with GCV in
the absence of this drug.
The mechanisms by which cell death induced by the HSV-tk/
GCV system occurs are not fully understood. Previous studies
have shown that the most likely mechanism of cell death is
apoptosis [50–53]. Release of cytochrome C and activation of
caspases are known to be involved, while the role of p53 protein
in the process of cell death is still a subject of some controversy
[54]. Aiming at gaining insights into the molecular mechan-
isms involved in the process of cell death induced by the HSV-
tk/GCV system, different experimental approaches were used
to evaluate the relative extent of apoptosis versus necrosis in
HSC-3 cells.
Our results clearly indicate that apoptosis is the main
mechanism involved in the death of HSC-3 cells upon their
treatment with the HSV-tk/GCV system, this being particularly
notorious upon increasing the incubation time with GCV (an
increase up to 50% of apoptotic cells after 6 days incubation
versus a residual value of 10% of necrotic cells over time).
These findings may be relevant for the clinical application of
this particular suicide gene therapy approach, since therapeutic
strategies involving tumor cell death through apoptosis are
advantageous as compared to those inducing necrosis, in which
case the release of death factors to medium can cause toxicity in
healthy tissue surrounding the tumor.
Our preliminary results in vivo clearly show an advantage of
using Tf-lipoplexes for intra-tumoral administration of HSV-tk
genes aiming at applying a suicide gene therapy approach. A
significant reduction of tumor growth was achieved using thesecomplexes, as compared to that observed with naked plasmid
DNA, which may be attributed not only to the ability of the
complexes to carry large copies of plasmid DNA, but also to the
recognized role of transferrin to promote cell internalization of
the associated complexes. Studies are in progress in our
laboratory, aiming at optimizing transfection conditions in
order to further improve the observed therapeutic effects, namely
in terms of tumor size reduction and ultimately of achieving its
complete eradication.
Overall, the present study shows that Tf-lipoplexes con-
stitute a promising system for the successful application of
suicide gene therapy approaches aiming at treating human oral
carcinomas.
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